CDRH Report: 24 Voluntary Diversity Action Plans Filed In 2024

 
• By Elizabeth Orr

While the US FDA will not require diversity action plans for clinical trials for a while, some companies are already sending them in, a new FDA report to Congress shows.

Diversity paper cutouts
Sponsors' clinical trial diversity action plans would benefit from FDA feedback, industry groups said. • Source: Shutterstock

More from Medtech Insight

More from ESG